Connect with us


Flowr acquires entirety of Holigen Holdings



Flowr Corporation (FLWR on Canadian Venture Exchange) (FLWPF on OTC Markets) Monday announced plans to fully acquire Holigen Holdings with the purchase of the remaining 80,2% stake in Holigen Holdings Ltd. Holigen owns the entirety of the Portuguese company RPK Biopharma, operating in Portugal as a project of “National Interest”.

Toronto Licensed Producer (LP) Flowr Corp has issued a statement announcing its intention to purchase all the shares of Holigen Holdings Ltd. Holigen is a European-based medical cannabis company that develops large-scale cultivation facilities, with activity in Portugal, namely in Sintra and Aljustrel.

“The full acquisition of Holigen is a natural evolution of our global cannabis strategy. The combination of Flowr's cultivation and facility design know-how with Holigen's global presence, expertise in good manufacturing practices and deep pharmaceutical expertise are an excellent combination. The opportunities in Europe and the Australian-Asian medical cannabis markets are enormous and Holigen has an unrivaled scale to serve these regions,” said Flowr CEO Vinay Tolia.

In December 2018, Flowr announced the acquisition of 19,8% of Holigen. Holigen's activity in Portugal is mainly carried out through the subsidiary RPK Biopharma. The latter awaits INFARMED's validations to start production in Sintra and Aljustrel, in a production that totals more than 400 tons of cannabis per year. This project has been designated a Project of National Interest by the Portuguese government, which guarantees special treatment and priority by government agencies and access to low-cost funding.

Increase the global scale

“Over this year, we've worked closely with Holigen's management to help develop their incredible assets, notably in Aljustrel, where the company has an outdoor growing facility. Aljustrel, which should be operational in the second half of 2019 — in a project with an expected production capacity of more than 500.000 kilograms per year. This acquisition positions Flowr to succeed with two distinct and economically sustainable strategies, the flower market in Canada and the large-scale market for medical extracts worldwide”, reads the statement signed by the CEO.

transaction details

The details of the transaction are known and according to the document published by the company, the purchase of Holigen will involve 32 million redeemable and convertible preference shares of Flowr, together with an amount of about 4,27 million euros. Flowr also agreed to pay an aggregate amount of around €1,4 million to various Holigen creditors, subject to the closing of the transaction. The purchase price will still be subject to re-analysis based on Holigen's cash amounts on the closing day of the transaction.

On Tuesday, Flowr shares were quoted at 5.87 US dollars


Click here to comment
Notify of
Inline feedback
View all comments

Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

Press Releases24 hours ago

Porto, Matosinhos, Valongo and Paredes – Eight arrested for drug trafficking and more than 8000 doses of drugs seized

The Porto Territorial Command, through the Criminal Investigation Center (NIC) of Santo Tirso, between the 20th and...

National2 days ago

Portugal: GNR seizes 3 tons of hashish in the Guadiana River

The Coastal and Border Control Unit (UCCF) of the National Republican Guard (GNR) seized last Friday, the 23rd...

Events2 days ago

Spannabis 2024: Barcelona hosts the 20th edition of the largest cannabis exhibition in the world, from March 15th to 17th

Barcelona is preparing to host the 20th edition of Spannabis, the largest cannabis fair in the world, on the 15th,...

International6 days ago

Germany: Bundestag voted today in favor of legalizing cannabis, but Federal Council approval is still needed

The Bundestag debated and voted this afternoon on the project to legalize the personal use of cannabis in the country, with 407...

International7 days ago

Germany: Legalization will be discussed this Friday, the 23rd

The German Bundestag will finally deliberate on the legalization of cannabis for personal consumption in the country. The debate, which has been...

Hemp1 weeks ago

Hemp cultivation in the Azores will have an information session on Terceira Island

The Confraria Internacional Cannabis Portugal and CannAzores join forces to promote an Information Session on the Cultivation of...

Health2 weeks ago

CBD and CBC show promising results in head and neck squamous cell carcinoma

A study published in the journal Cancers found that cannabis extracts rich in CBD (cannabidiol) can kill breast cancer cells...

International2 weeks ago

Ukraine: Zelensky signs bill to legalize medical cannabis

Ukrainian President Volodymyr Zelensky signed a bill legalizing medical cannabis in Ukraine, with the expectation that...

National3 weeks ago

Portugal: Associação Mães pela Canábis publishes e-book on medicinal cannabis

The Association of Mothers for Cannabis (AMC) announced the launch of an e-book entitled “Frontiers of Cannabis: SCIENCE, THERAPEUTICS &...

corporations4 weeks ago

Akanda signs letter of intent to sell RPK Biopharma to Somaí. “It will be one of the few vertical cannabis companies in the EU”, says Michael Sassano

Akanda Corporation, an international medical cannabis company listed on Nasdaq (AKAN) and which owns the Portuguese company Holigen, announced...